Icon
+91 94997 68112
Login Register

DAWNZERA (AUTOINJECTOR) - (EQ 80MG BASE/0.8ML (EQ 80MG BASE/0.8ML) ; Solution)

DONIDALORSEN SODIUM IONIS PHARMS INC
EQ 80MG BASE/0.8ML (EQ 80MG BASE/0.8ML) ; Solution
Less Than $1000 mn
None None
None None
None None
DAWNZERA is a prekallikrein-directed antisense oligonucleotide indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.
Yes
DAWNZERA (AUTOINJECTOR) Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
*** *********
******* *** ********** ********** (*****) ********** ********** ********* ********* *** ***** *** ********** ********* ********* *** ***** *** ********** ** ************* (***) ********** ************ *** ******* *** ********** *** **********

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.